arrow
T

Takuro Saito

The University of Osaka
H指数:32
被引数:7,706

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Shotgun metagenomic sequencing of serum extracellular vesicle-derived DNA enables microbial profiling in urothelial carcinoma

血清外泌体来源DNA的宏基因组测序可实现对尿路上皮癌的微生物谱分析

2026-09-250
OAAI
Clinical practice guidelines for duodenal cancer 2025

2025年十二指肠癌临床实践指南

2026-09-050
PRE
Everolimus-Involving Immunosuppression Attenuates Renal Interstitial Fibrosis Through Modulation of Mammalian Target of Rapamycin-Related Signal Transduction

依维莫司介导的免疫抑制通过调节哺乳动物雷帕霉素靶蛋白相关信号转导减轻肾间质纤维化

2026-08-270
OA
PD-1 antibody-bound progenitor-exhausted CD8+ T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer

PD-1抗体结合的祖细胞耗竭性CD8+ T细胞在淋巴结中增强PD-1阻断在胃肠道癌症中的抗肿瘤免疫。

2026-04-080
OAAI
Tumor-associated high endothelial venules are associated with enhanced lymphocyte infiltration and favorable prognosis in resected hepatocellular carcinoma

肿瘤相关高内皮静脉与切除的肝细胞癌中淋巴细胞浸润增强及良好预后相关

2025-12-190
OAAI
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study

不可切除或复发性胃肠道间质瘤综合基因组分析的临床意义:一项多中心回顾性队列研究

2025-11-210
PRE
Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy

转铁蛋白受体在食管鳞状细胞癌中的过表达提示预后不良及潜在治疗可能性

2025-11-010
OAAI
Efficacy and safety of pimitespib in gastrointestinal tumors

Pimitespib在胃肠道肿瘤中的疗效与安全性

2025-11-010
PRE
Prognostic Impact of Immunoscore in Pathological Stage III Differentiated Gastric Cancer: A Multicenter Cohort Study Including PD-L1/PD-L2 Expression Analysis

免疫评分在病理分期III期分化型胃癌中的预后影响:一项包括PD-L1/PD-L2表达分析的多中心队列研究

2025-10-290
OAAI
Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial

阿纳莫林(anamorelin)治疗不可切除或复发性胃癌患者癌性恶病质的有效性和安全性:一项多中心、开放标签、随机对照试验

2025-09-220
OAAI
Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells

靶向yes相关蛋白以克服胃肠道间质瘤药物耐受持久细胞的伊马替尼耐药性

2025-09-080
OAAI
Clinical impact of primary and secondary KIT mutations on the efficacy of molecular-targeted therapies in gastrointestinal stromal tumors

原发性与继发性KIT突变对胃肠道间质瘤分子靶向治疗疗效的临床影响

2025-07-230
OAAI
High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance

食管鳞癌中恶病质相关蛋白Fn14的高表达与化疗反应差相关,anti-Fn14治疗降低化疗耐药性

2025-07-150
PRE